Advertisement
Research Article| Volume 9, ISSUE 1, P13-18, March 1999

The medical and surgical management of recurrent miscarriage

DOI:https://doi.org/10.1016/S0957-5847(99)90067-7
The medical and surgical management of recurrent miscarriage
Previous ArticleAntiphospholipid antibodies and the investigation of recurrent miscarriage
Next ArticlePsychological aspects of spontaneous and recurrent abortion
      This paper is only available as a PDF. To read, Please Download here.

      Abstract

      Recurrent miscarriage is suffered by 1% of couples. It is extremely distressing causing stress to the woman and her family. A careful history and investigation can elicit a cause in around 50% of cases. Early pregnancy support and targeted treatments can increase the likelihood of success to approximately 80% in the subsequent pregnancy. Possible treatments include psychological support, aspirin, hCG injections and cervical cerclage, but these need to be considered carefully and explained fully to the couple before being tried. Extravagant claims and inappropriate, potentially dangerous therapies must be avoided. Management is best performed in specialized units with experience in this area.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Obstetrics, Gynaecology and Reproductive Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Register: Create an account
      Institutional Access: Sign in to ScienceDirect

      References

        • Li T.C.
        Recurrent miscarriage: principles of management.
        Hum Reprod. 1998; 13: 478-482
        • Drakeley A.J.
        • Quenby S.
        • Farquharson R.G.
        Mid-trimester loss-appraisal of a screening protocol.
        Hum Reprod. 1998; 13: 1975-1980
        • Stirrat G.M.
        Recurrent miscarriage I: definition and epidemiology.
        Lancet. 1990; 336: 673-675
        • Clifford K.
        • Rai R.
        • Watson H.
        • Regan L.
        An informative protocol for the investigation of recurrent miscarriage — preliminary experience of 500 consecutive cases.
        Human Reproduction. 1994; 9: 1328-1332
        • Roberts J.
        • Jenkins C.
        • Wilson R.
        • et al.
        Recurrent miscarriage is associated with increased numbers of cd5/20 positive lymphocytes and an increased incidence of thyroid antibodies.
        European Journal Of Endocrinology. 1996; 134: 84-86
        • Rai R.
        • Cohen H.
        • Dave M.
        • Regan L.
        Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies).
        BMJ. 1997; 314: 253-257
        • Rai R.
        • Regan L.
        Antiphospholipid antibodies, infertility and recurrent miscarriage.
        Current Opinion in Obstetrics & Gynecology. 1997; 9: 279-282
        • Maneschi I.
        • Maneschi F.
        • Parlato M.
        • Fuca G.
        • Incandela S.
        Reproductive performance in women with uterus didelphys.
        Acta Eur Fertil. 1989; 20: 121-124
        • Anthony G.S.
        • Fisher J.
        • McManus T.J.
        • Coutts J.R.T.
        • Calder A.A.
        Forces required for dilatation of the pregnant and non-pregnant human cervix.
        Br J Obstet Gynaecol. 1982; 89: 913-916
        • Flint S.
        • Gibb D.M.F.
        Recurrent second trimester miscarriage.
        Current Opinion In Obstetrics & Gynecology. 1996; 8: 449-453
        • Guzman E.R.
        • Mellon C.
        • Vintzileos A.M.
        • Ananth C.V.
        • Walters C.
        • Gipson K.
        Longitudinal assessment of endocervical canal length between 15 and 24 weeks' gestation in women at risk for pregnancy loss or preterm birth.
        Obstet Gynecol. 1998; 92: 31-37
        • Chasen S.T.
        • Silverman N.S.
        Mid-trimester emergent cerclage: a ten year single institution review.
        J Perinatol. 1998; 18: 338-342
        • Heath V.C.
        • Souka A.P.
        • Erasmus I.
        • Gibb D.M.
        • Nicolaides K.H.
        Cervical length at 23 weeks of gestation: the value of Shirodkar suture for the short cervix.
        Ultrasound Obstet Gynecol. 1998; 12: 318-322
        • Quenby S.M.
        • Farquharson R.G.
        Predicting recurring miscarriage — what is important.
        Obstetrics And Gynecology. 1993; 82: 132-138
        • Clifford K.
        • Rai R.
        • Watson H.
        • Regan I.
        An informative protocol for the investigation of recurrent miscarriage: preliminary experience of 500 consecutive cases.
        Hum Reprod. 1994; 9: 1328-1332
        • Walker J.J.
        • Shilito J.
        Early pregnancy units: service and organisational aspects.
        in: Grudzinskas J.G. O'Brien P.M.S. Problems in early pregnancy: advances in diagnosis and management. RCOG Press, London1997: 160-173
        • Clifford K.
        • Rai R.
        • Regan L.
        Future pregnancy outcome in unexplained recurrent first trimester miscarriage.
        Hum Reprod. 1997; 12: 387-389
        • Clifford K.
        • Rai R.
        • Watson H.
        • Franks S.
        • Regan L.
        Does suppressing luteinizing-hormone secretion reduce the miscarriage rate — results of a randomized controlled trial.
        British Medical Journal. 1996; 312: 1508-1511
        • Harrison R.F.
        Miscarriage — hormonal treatment with hcg.
        Contraception Fertilite Sexualite. 1991; 19: 373-376
        • Harrison R.
        Human chorionic gonadotrophin in the management of recurretn abortion: results of a multicentre placebo controlled study.
        Eur J Obstet Gynecol Reprod Biol. 1992; 72: 175-179
        • Quenby S.
        • Farquharson R.G.
        Human chorionic gonadotrophin supplementation in recurring pregnancy loss. A controlled trial.
        Fertil Steril. 1994; 62: 708-710
        • Rai R.
        • Cohen H.
        • Dave M.
        • Regan L.
        Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies).
        BMJ. 1997; 314: 253-257
        • Harris E.N.
        • Pierangeli S.S.
        Utilization of intravenous immunoglobulin therapy to treat recurrent pregnancy loss in the antiphospholipid syndrome: a review.
        Scand J Rheumatol Suppl. 1998; 107: 97-102
        • Sher G.
        • Matzner W.
        • Feinman M.
        • et al.
        The selective use of heparin/aspirin therapy, alone or in combination with intravenous immunoglobulin G, in the management of antiphospholipid antibody-positive women undergoing in vitro fertilization.
        Am J Reprod Immunol. 1998; 40: 74-82
        • Christiansen O.B.
        Intravenous immunoglobulin in the prevention of recurrent spontaneous abortion: the European experience.
        Am J Reprod Immunol. 1998; 39: 77-81
        • Maejima M.
        • Fujii T.
        • Yamashita T.
        • et al.
        Immunotherapy before and during pregnancy improves pregnancy outcome in womenwho suffer from recurrent abortion and did not benefit from immunotherapy before pregnancy.
        Am J Reprod Immunol. 1998; 39: 12-15
        • Jeng G.T.
        • Scott J.R.
        • Burmeister L.F.
        A comparison of metaanalytic results using literature vs individual patient data — paternal cell immunization for recurrent miscarriage.
        Journal Of The American Medical Association. 1995; 274: 830-836
        • March C.M.
        • Israel R.
        Hysteroscopic management of recurrent abortion caused by septate uterus.
        Am J Obstet Gynecol. 1987; 156: 834-842
        • Shirodkar V.N.
        A new method of operative treatment for habitual abortion in the second trimester of pregnancy.
        Antiseptic. 1955; 52: 299-300
        • McDonald I.A.
        Suture of the cervix for inevitable miscarriage.
        J Obstet Gynaecol Br Emp. 1957; 64: 346-353
      31. Final report of the Medical Research Council/Royal College of Obstetricians and Gynaecologists multicentre randomised trial of cervical cerclage MRC/RCOG Working Party on Cervical Cerclage.
        Br J Obstet Gynaecol. 1993; 100: 516-523
        • Gibb D.M.F.
        • Salaria D.A.
        Transabdominal cervicoisthmic cerclage in the management of recurrent 2nd-trimester miscarriage and preterm delivery.
        Br J Obstet Gynaecol. 1995; 102: 802-806
        • Anthony G.S.
        • Walker R.G.
        • Cameron A.D.
        • Price J.L.
        • Walker J.J.
        • Calder A.A.
        Transabdominal cervico-isthmic cerclage in the management of cervical incompetence.
        Eur J Obstet Gynecol Reprod Biol. 1997; 72: 127-130
        • Novy M.J.
        Transabdominal cervicoisthmic cerclage: a reappraisal 25 years after its introduction.
        Am J Obstet Gynecol. 1991; 164: 1635-1641
        • Novy M.J.
        Transabdominaal cervicoisthmic cerclage for the management of repetitive abortion and premature delivery.
        Am J Obstet Gynecol. 1982; 143: 44-54
        • Clifford K.
        • Rai R.
        • Regan L.
        Future pregnancy outcome in unexplained recurrent first trimester miscarriage.
        Human Reproduction. 1997; 12: 387-389

      Article info

      Identification

      DOI: https://doi.org/10.1016/S0957-5847(99)90067-7

      Copyright

      © 1999 Published by Elsevier Inc.

      ScienceDirect

      Access this article on ScienceDirect
      We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the for this site.
      Copyright © 2023 Elsevier Inc. except certain content provided by third parties. The content on this site is intended for healthcare professionals.


      RELX